HHS-OIG HHS OIG Reviews FDA’s Accelerated Approval of Aducanumab Thomas Sullivan Mar 12, 2025 0 Earlier this year, the United States Department of Health and Human Services Office of the Inspector General (HHS OIG) conducted a…
FDA IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease Thomas Sullivan May 26, 2010 0 In 2008, the Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a study on the evaluation…
